{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:25:25Z","timestamp":1793384725259,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100018854","name":"Sirtex Medical Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018854","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jvir.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T05:18:42Z","timestamp":1720934322000},"page":"1591-1600.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Outcomes Analysis of Yttrium-90 Radioembolization for Tumors Other Than Metastatic Colorectal Cancer from the Radiation-Emitting SIR-Spheres in Nonresectable (RESiN) Registry"],"prefix":"10.1016","volume":"35","author":[{"given":"Wenhui","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0533-2883","authenticated-orcid":false,"given":"Daniel B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4916-1377","authenticated-orcid":false,"given":"Rajesh P.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Y.","family":"Sze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2024.07.006_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41572-021-00261-6","article-title":"Liver metastases","volume":"7","author":"Tsilimigras","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jvir.2024.07.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2020.101760","article-title":"Epidemiology of liver metastases","volume":"67","author":"Horn","year":"2020","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib5","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.jvir.2022.08.031","article-title":"Transarterial radioembolization for hepatic metastases of pancreatic adenocarcinoma: a systematic review","volume":"33","author":"Alexander","year":"2022","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.tvir.2019.02.008","article-title":"Y90 clinical data update: cholangiocarcinoma, neuroendocrine tumor, melanoma, and breast cancer metastatic disease","volume":"22","author":"Padia","year":"2019","journal-title":"Tech Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0038-1636518","article-title":"Locoregional therapies for the treatment of hepatic metastases from breast and gynecologic cancers","volume":"35","author":"Mouli","year":"2018","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jvir.2018.01.775","article-title":"Response and overall survival for yttrium-90 radioembolization of hepatic sarcoma: a multicenter retrospective Study","volume":"29","author":"Miller","year":"2018","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00270-020-02642-y","article-title":"Clinical application of trans-arterial radioembolization in hepatic malignancies in Europe: first results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT)","volume":"44","author":"Helmberger","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib10","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211350","article-title":"Oligometastatic disease in the liver: the role of interventional oncology","volume":"95","author":"Adnan","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1148\/radiol.220387","article-title":"Survival and toxicities after 90Y transarterial radioembolization of metastatic colorectal cancer in the RESIN Registry","volume":"305","author":"Emmons","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2024.07.006_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jvir.2021.03.535","article-title":"Multicenter evaluation of survival and toxicities of hepatocellular carcinoma following radioembolization: analysis of the RESiN Registry","volume":"32","author":"Frantz","year":"2021","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jvir.2022.10.042","article-title":"Survival and toxicities after yttrium-90 transarterial radioembolization of cholangiocarcinoma in the RESiN Registry","volume":"34","author":"Robinson","year":"2023","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2024.07.006_bib14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12885-022-09302-z","article-title":"Long-term outcomes following 90Y radioembolization of neuroendocrine liver metastases: evaluation of the Radiation-Emitting SIR-spheres in Non-resectable liver tumor (RESiN) registry","volume":"22","author":"Wong","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jvir.2024.07.006_bib15","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2024.07.006_bib16","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1158\/1078-0432.CCR-12-3796","article-title":"New data supporting modified RECIST (mRECIST) for hepatocellular carcinoma","volume":"19","author":"Lencioni","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jvir.2024.07.006_bib20","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.21037\/tcr-20-3319","article-title":"Incidence and survival outcomes of secondary liver cancer: a Surveillance Epidemiology and End Results database analysis","volume":"10","author":"Wang","year":"2021","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.jvir.2024.07.006_bib21","first-page":"1477","article-title":"Incidence and prognosis of liver metastasis at diagnosis: a pan-cancer population-based study","volume":"10","author":"Wang","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.jvir.2024.07.006_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-07968-5","article-title":"Risk and prognostic factors of breast cancer with liver metastases","volume":"21","author":"Ji","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jvir.2024.07.006_bib23","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1002\/cam4.2453","article-title":"Metastatic breast cancer patients with lung or liver metastases should be distinguished before being treated with fulvestrant","volume":"8","author":"He","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jvir.2024.07.006_bib24","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.18_suppl.LBA3","article-title":"ANNOUNCE: a randomized, placebo (PBO)-controlled, double-blind, phase (Ph) III trial of doxorubicin (dox)\u00a0+ olaratumab versus dox\u00a0+ PBO in patients (pts) with advanced soft tissue sarcomas (STS)","volume":"37","author":"Tap","year":"2019","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2024.07.006_bib25","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1510016","article-title":"Cabozantinib versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Choueiri","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jvir.2024.07.006_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.ijrobp.2011.07.020","article-title":"Radiotherapy for liver metastases: a review of evidence","volume":"82","author":"H\u00f8yer","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2024.07.006_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0360-3016(95)02029-2","article-title":"A\u00a0review of human cell radiosensitivity in\u00a0vitro","volume":"34","author":"Deschavanne","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2024.07.006_bib28","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/S1470-2045(21)00572-6","volume":"22","author":"Strosberg","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jvir.2024.07.006_bib29","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1200\/JCO.21.01839","article-title":"Radioembolization with chemotherapy for colorectal liver metastases: a randomized, open-label, international, multicenter, phase III trial","volume":"39","author":"Mulcahy","year":"2021","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2024.07.006_bib30","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2147\/JHC.S318865","article-title":"A\u00a0prospective phase II study of safety and efficacy of sorafenib followed by 90Y glass microspheres for patients with advanced or metastatic hepatocellular carcinoma","volume":"8","author":"Kaseb","year":"2021","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.jvir.2024.07.006_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2024.07.006_bib32","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2967\/jnumed.117.202937","article-title":"Retrospective voxel-based dosimetry for assessing the ability of the body-surface-area model to predict delivered dose and radioembolization outcome","volume":"59","author":"Kafrouni","year":"2018","journal-title":"J\u00a0Nucl Med"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324004548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044324004548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T04:45:06Z","timestamp":1729658706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044324004548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1051044324004548"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2024.07.006","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes Analysis of Yttrium-90 Radioembolization for Tumors Other Than Metastatic Colorectal Cancer from the Radiation-Emitting SIR-Spheres in Nonresectable (RESiN) Registry","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2024","name":"copyright","label":"Copyright"}]}}